Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SVA

Sinovac Biotech (SVA)

Sinovac Biotech Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SVA
DateTimeSourceHeadlineSymbolCompany
30/04/202407:53Business WireSINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FNASDAQ:SVASinovac Biotech Ltd
21/02/202422:09Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:SVASinovac Biotech Ltd
21/02/202422:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
21/02/202418:56Business WireSinovac Amends Shareholder Rights PlanNASDAQ:SVASinovac Biotech Ltd
03/02/202403:19Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
19/01/202422:58Business Wireシノバック取締役会、一方的な部分公開買い付けを全会一致で退けるNASDAQ:SVASinovac Biotech Ltd
19/01/202406:54Business WireSinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案NASDAQ:SVASinovac Biotech Ltd
19/01/202406:47Business WireLe conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
19/01/202405:33Business WireDas Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot abNASDAQ:SVASinovac Biotech Ltd
18/01/202423:13Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
18/01/202423:00Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
09/01/202408:46Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SVASinovac Biotech Ltd
04/12/202322:01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
04/10/202300:39Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
15/09/202322:59Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
12/09/202320:10Business Wireシノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告NASDAQ:SVASinovac Biotech Ltd
12/09/202300:36Business WireSINOVAC rend compte des progrès réalisés dans le cadre de son essai clinique concernant l’injection anti-COVID-19 à base d’anticorps SA55NASDAQ:SVASinovac Biotech Ltd
12/09/202300:36Business WireSINOVAC informiert über die Fortschritte bei der klinischen Studie für den Anti-COVID-19-Antikörper SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
11/09/202320:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
11/09/202319:55Business WireSINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
06/09/202321:35Business Wireシノバック取締役会、同意なき株式の部分公開買付を全会一致で拒否NASDAQ:SVASinovac Biotech Ltd
06/09/202302:16Business WireSinovac-Vorstand lehnt ein unangefordertes Teilübernahmeangebot einstimmig abNASDAQ:SVASinovac Biotech Ltd
06/09/202301:36Business WireLe conseil d’administration de Sinovac rejette à l’unanimité une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
05/09/202321:04Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
05/09/202318:12Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
30/08/202303:08Business Wireシノバック、部分的な株式公開買付を一方的に受けたことを確認NASDAQ:SVASinovac Biotech Ltd
29/08/202323:04Business WireSinovac bestätigt den Erhalt eines unangeforderten TeilübernahmeangebotsNASDAQ:SVASinovac Biotech Ltd
29/08/202320:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
29/08/202320:05Business WireSinovac confirme la réception d'une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
29/08/202317:07Business WireSinovac Confirms Receipt of an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
 Showing the most relevant articles for your search:NASDAQ:SVA

Your Recent History